Interested in purchasing Omnigen?

Register your interest

Click Here

Have a question about our products or pipelines?

Speak to our team of experts

Click Here

Saving sight through an innovative vision

NuVision was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma.

Introducing Omnigen™

Omnigen™ is a unique ‘off the shelf’, transportable biological matrix that can be used as an effective ophthalmic wound dressing and to treat ocular surface indications.

A message from our CEO

With a strong, experienced team, supported by a history of innovative research, we have the products that have the potential to revolutionise ophthalmic wound care worldwide.  Having over 15 year’s expertise in ocular regenerative medicine, and personally evolving Omnigen™ from concept to commercialisation, I believe NuVision has endless potential for growth.

Andrew Hopkinson

Founder and CEO, NuVision Biotherapies

Introducing Tereo™

The Tereo™ process is a patented and proprietary manufacturing procedure which renders fresh amniotic membrane, and thus associated wound healing promoting characteristics, as a dry and stable biological matrix that can be distributed and stored at room temperature on the shelf of any medical facility. Tereo processed amniotic membrane (Omnigen) can be used directly from the packaging dry with ease allowing rapid in vivo rehydration from eye moisture.

Latest News

Omnigen™ back on the BBC!

The BBC was fascinated that the exceptional healing potential of Omnigen isn’t just limited to humans. After interviewing Iain, who described how Omnigen had helped restore his sight after 12 years of eye problems, BBC East Midlands Today featured another... read more

Connect with Us

The #BBC featured another happy patient who received #Omnigen treatment: Bandit the #frenchbulldog: https://t.co/VRrC0dnumH #savingsight
- Wednesday Jul 20 - 10:21am

#Omnigen reaches Scotland https://t.co/1moef0RR3A
- Tuesday Jul 19 - 6:00pm